For instance, p53 deficiency in myeloid lineage accelerates tumourigenesis in an intestinal cancer model, and activation of p53 attenuates the inflammatory response and resists tumor development (Figure 1; Guo et al., 2013; He et al., 2015). The gene discussed is TP53; the disease is intestinal cancer.